Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00150_DB06684_nanopub.RAd6fPmkYT7XVtYZHXFKvy9X5z1NxVBVlBfeT5P3ddEUc#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00150_DB06684 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00150_DB06684 label "DDI between L-Tryptophan and Vilazodone - Due to risks of enhanced serotonin activity and/or adverse reactions (e.g., serotonin syndrome), concomitant use of selective serotonin reuptake inhibitors (SSRIs) and tryptophan is not recommended. Avoid combination. [drugbank_resource:DB00150_DB06684]" assertion.
- drugbank_resource:DB00150_DB06684 identifier "drugbank_resource:DB00150_DB06684" assertion.
- drugbank_resource:DB00150_DB06684 title "DDI between L-Tryptophan and Vilazodone - Due to risks of enhanced serotonin activity and/or adverse reactions (e.g., serotonin syndrome), concomitant use of selective serotonin reuptake inhibitors (SSRIs) and tryptophan is not recommended. Avoid combination." assertion.
- drugbank:DB06684 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00150_DB06684 assertion.
- drugbank:DB00150 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00150_DB06684 assertion.